3Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS [ J ]. Crit Care Med, 1996, 24(7) : 1125-1128. 被引量：1
4Opal SM, Laterre PF, Francois B, et al. Effect of eritoran, an antagonist of MD2-TLR4, on mortality in patients with severe sepsis : the ACCESS randomized trial [ J ]. JAMA, 2013,309 ( 11 ): 1154-1162. 被引量：1
5Limaye AP, Kirby KA, Rubenfeld GD, et al. Cytomegalovirus reactivation in critically ill immunocompetent patients [ J ]. JAMA, 2008, 300(4) : 413-422. 被引量：1
6Boomer JS, To K, Chang KC, et al. Immunosuppression in patients who die of sepsis and multiple organ failure [ J ]. JAMA, 2011,306 (23) : 2594-2605. 被引量：1
7Felmet KA, Hall MW, Clark RS, et al. Prolonged lymphopenia, lymphoid depletion, and hypoprolactinemia in children with nosocomial sepsis and multiple organ failure [ J ]. J Immunol, 2005, 174(6) : 3765-3772. 被引量：1
8Hamilton JA. Colony-stimulating factors in inflammation and autoimmunity [ J ]. Nat Rev Immunol, 2008, 8 (7) : 533-544. 被引量：1
9Bo L, Wang F, Zhu J, et al. Granuloeyte-coIony stimulating factor (G-CSF) and granulocyte-macrophage colony stimulating factor (GM-CSF) for sepsis : a meta-analysis [ J ]. Crit Care, 2011, 15 (1) :R58. 被引量：1
